IRMD · NASDAQ
iRadimed (IRMD) Stock Price & Fundamentals
iRadimed (IRMD) closed at $566.43 on Oct 9, 2026, up 0.06% from the previous close of $566.11.
Share price, past year
1Y +6.82%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $566.43 |
| Sep 30, 2026 | $568.34 |
| Aug 31, 2026 | $583.73 |
| Jul 31, 2026 | $587.38 |
| Jun 30, 2026 | $570.17 |
| May 29, 2026 | $560.39 |
| Apr 30, 2026 | $507.39 |
| Mar 31, 2026 | $520.62 |
| Feb 27, 2026 | $536.75 |
| Jan 30, 2026 | $551.05 |
| Dec 31, 2025 | $528.05 |
| Nov 28, 2025 | $503.90 |
| Oct 31, 2025 | $510.09 |
Key statistics
- Market cap
- $7.24B
- P/E (TTM)
- 316.4
- EPS (TTM)
- $1.79
- Revenue (TTM)
- $86.34M
- Net income (TTM)
- $23.06M
- Shares outstanding
- 12.8M
- Dividend yield
- —
- 52-week range
- $498.05 – $599.53
iRadimed's market cap is $7.24B, based on a share price of $566.43 and 12.8M shares outstanding as of Jun 30, 2026.
Financials
iRadimed reported revenue of $83.81M for fiscal 2025, up 14.43% from fiscal 2024.
iRadimed earned net income of $22.48M in fiscal 2025, a net margin of 26.8%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $83.81M | +14.4% | $22.48M | 26.8% | $1.75 | $17.18M |
| FY2024ended Dec 31, 2024 | $73.24M | +11.7% | $19.23M | 26.3% | $1.50 | $17.62M |
| FY2023ended Dec 31, 2023 | $65.56M | +23.0% | $17.19M | 26.2% | $1.35 | $6.02M |
| FY2022ended Dec 31, 2022 | $53.30M | +27.5% | $12.83M | 24.1% | $1.02 | $9.22M |
| FY2021ended Dec 31, 2021 | $41.81M | +31.8% | $9.33M | 22.3% | $0.74 | $10.78M |
| FY2020ended Dec 31, 2020 | $31.72M | −17.7% | $1.37M | 4.3% | $0.11 | $5.37M |
| FY2019ended Dec 31, 2019 | $38.52M | +26.5% | $9.63M | 25.0% | $0.78 | $9.86M |
| FY2018ended Dec 31, 2018 | $30.44M | +31.9% | $6.30M | 20.7% | $0.52 | $7.15M |
| FY2017ended Dec 31, 2017 | $23.08M | −29.0% | $499.76K | 2.2% | $0.04 | $2.64M |
| FY2016ended Dec 31, 2016 | $32.50M | — | $7.21M | 22.2% | $0.60 | $8.63M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $20.47M | $5.22M | $0.41 |
| Q1 FY2026ended Mar 31, 2026 | $21.98M | $5.82M | $0.45 |
| Q4 FY2025ended Dec 31, 2025 | $22.69M | $6.44M | $0.50 |
| Q3 FY2025ended Sep 30, 2025 | $21.20M | $5.58M | $0.43 |
| Q2 FY2025ended Jun 30, 2025 | $20.41M | $5.77M | $0.45 |
| Q1 FY2025ended Mar 31, 2025 | $19.51M | $4.69M | $0.37 |
| Q4 FY2024ended Dec 31, 2024 | $19.39M | $5.15M | $0.40 |
| Q3 FY2024ended Sep 30, 2024 | $18.33M | $5.05M | $0.40 |
Company profile
- Name
- iRadimed Corporation
- Ticker
- IRMD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 12705 Ingenuity Drive, Orlando, FL 32826
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001325618
Recent SEC filings
- Jul 31, 2026
- Jul 31, 2026
- Jun 24, 2026
- May 1, 2026
- May 1, 2026
- Mar 6, 2026
- Feb 10, 2026
- Dec 8, 2025
Frequently asked questions
What is iRadimed's stock price?
iRadimed (IRMD) closed at $566.43 on Oct 9, 2026, up 0.06% from the previous close of $566.11.
What is iRadimed's market cap?
iRadimed's market cap is $7.24B, based on a share price of $566.43 and 12.8M shares outstanding as of Jun 30, 2026.
How much revenue does iRadimed make?
iRadimed reported revenue of $83.81M for fiscal 2025, up 14.43% from fiscal 2024.
What is IRMD's P/E ratio?
iRadimed's price-to-earnings ratio is 316.4, based on trailing twelve-month diluted EPS of $1.79.
Does iRadimed pay a dividend?
iRadimed's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from iRadimed Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures